IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated DiseaseKirk A. Staschke, Songqing Na|The Journal of Immunology|2009Cited by 54
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E. Stokes, David Surguladze, Nupur Ballal et al.|Clinical Cancer Research|2023Cited by 27
Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancerRicardo A. Cordova, Kirk A. Staschke|Science Signaling|2024Cited by 9
GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasisRicardo A. Cordova, Kirk A. Staschke|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 4
Abstract 6231: Activation of GCN2 by HC-7366 results in significant antitumor efficacy as monotherapy and in combination with multiple standard of care agents in various solid cancer modelsFeven Tameire, Nandita Bose, Paulina M. Wojnarowicz et al.|Cancer Research|2023Cited by 3